| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.7 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.7 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |